60 Degrees Pharmaceuticals, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.29-$17.64 |
Market Cap | $4.3M |
Shares Short | 484,774 |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | 256.9% |
Gross Profit (12 Mos) | $585,855 |
Diluted EPS | -$11.73 |
News
See moreYahoo Finance • 3 days ago
60 Degrees Pharmaceuticals Announces 2025 Annual Results
Yahoo Finance • 3 months ago
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
Yahoo Finance • 4 months ago
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine
Yahoo Finance • 5 months ago
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
About
CEO | Dr. Geoffrey Stuart Dow Ph.D. |
CFO | Mr. Tyrone Miller |
Address | 1025 Connecticut Avenue NW, Washington, DC, United States, 20036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3 |
